Related Experiment Video
Updated: Apr 19, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Translating the MAM model of psychosis to humans
Gemma Modinos1, Paul Allen1, Anthony A Grace2
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Abstract:
Elevated dopamine function and alterations in medial temporal lobe (MTL) structure and function are two of the most robust findings in schizophrenia, but how interactions between these abnormalities underlie the onset of psychosis is unclear. The methylazoxymethanol acetate (MAM) rodent model proposes that psychosis develops as a result of a perturbation of MTL function, leading to elevated striatal dopamine dysfunction. Here, we review several recent neuroimaging studies that examine components of the putative model in humans with an ultra high risk (UHR) of the psychosis. While data from these studies are broadly consistent with the MAM model, caution is required when comparing data across animal and human studies.
Insights
Schizophrenia research suggests medial temporal lobe (MTL) changes and dopamine dysfunction may interact to cause psychosis. Human studies in individuals at ultra-high risk (UHR) show findings consistent with the methylazoxymethanol acetate (MAM) model.
Area of Science:
- Neuroscience
- Psychiatry
- Neuroimaging
Background:
- Schizophrenia is characterized by elevated dopamine function and medial temporal lobe (MTL) structural/functional alterations.
- The interplay between these abnormalities in psychosis onset remains poorly understood.
- The methylazoxymethanol acetate (MAM) rodent model links MTL dysfunction to striatal dopamine abnormalities.
Purpose of the Study:
- To review neuroimaging studies investigating components of the MAM model in humans.
- To examine human data from individuals at ultra-high risk (UHR) for psychosis.
- To assess the consistency of human findings with the MAM rodent model.
Main Methods:
- Review of recent neuroimaging studies.
- Focus on human participants with ultra-high risk (UHR) for psychosis.
- Comparison of human neuroimaging data with predictions from the MAM model.
Main Results:
- Neuroimaging findings in UHR individuals are broadly consistent with the MAM model's proposed mechanisms.
- Evidence supports a link between MTL alterations and dopamine system dysfunction in psychosis development.
- Specific components of the MAM model are supported by human data.
Conclusions:
- Human neuroimaging data align with the MAM model's hypothesis regarding psychosis development.
- The MAM model provides a useful framework for understanding schizophrenia pathophysiology.
- Further research is needed to refine cross-species comparisons and fully validate the model in humans.
More Related Videos
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Psychological and Sociocultural Causes of Schizophrenia
Stereotype Content Model